Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple drug resistance.

L A Mitscher1, S P Pillai, E J Gentry

  • 1Department of Medicinal Chemistry, Kansas University, Lawrence, Kansas 66045-2506, USA. lmitscher@rx.pharm.ukans.edu

Medicinal Research Reviews
|November 11, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feeding stimulatory and inhibitory chemicals from an acceptable nonhost plant forManduca sexta: Improved detection by larvae deprived of selected chemosensory organs.

Journal of chemical ecology·2013
Same author

Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma.

Veterinary and comparative oncology·2013
Same author

The Medicinal and Bioorganic Chemistry Foundation--third winter conference. 23-29 January 1999, Steamboat Springs, CO, USA.

IDrugs : the investigational drugs journal·2005
Same author

Antimutagenic/antioxidant activity of green tea components and related compounds.

Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer·2004
Same author

The ability of certain antimutagenic agents to prevent development of antibiotic resistance.

Mutation research·2001
Same author

Role of antimutagens/anticarcinogens in cancer prevention.

BioFactors (Oxford, England)·2001

Drug resistance to antibacterial, antifungal, antiviral, antiprotozoal, and antitumor agents is a growing global health threat. This review explores the origins, scope, current strategies, and future directions for combating antimicrobial and anticancer drug resistance.

Area of Science:

  • Microbiology
  • Pharmacology
  • Oncology

Background:

  • Multiple drug resistance (MDR) has dramatically increased across antibacterial, antifungal, antiviral, antiprotozoal, and antitumor agents.
  • This escalating resistance poses a significant threat to the efficacy of current chemotherapy treatments in diverse medical fields.

Purpose of the Study:

  • To review the origins and current extent of MDR.
  • To summarize existing methods for combating MDR.
  • To highlight promising future strategies for overcoming drug resistance.

Main Methods:

  • Literature review of scientific publications on drug resistance.
  • Synthesis of information on the causes and prevalence of MDR.
  • Analysis of current therapeutic approaches and future research directions.

Related Experiment Videos

Main Results:

  • Drug resistance is a complex phenomenon with diverse origins.
  • The scope of MDR is extensive, impacting multiple classes of therapeutic agents.
  • Various strategies are being employed, but novel approaches are urgently needed.

Conclusions:

  • Addressing MDR requires a multifaceted approach, integrating current knowledge with innovative research.
  • Continued research into the mechanisms of resistance and development of new therapeutic agents is critical.
  • Effective management of MDR is essential to preserve the success of chemotherapy and public health.